Holen Sie sich die Stockscreener-App
1.86
6.05%
0.1061
Vorhandelsmarkt:
1.87
0.01
+0.54%
Schlusskurs vom Vortag:
$1.7539
Offen:
$1.71
24-Stunden-Volumen:
14,411
Relative Volume:
0.23
Marktkapitalisierung:
$4.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.91%
1M Leistung:
-4.12%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.71
$1.86
1-Wochen-Bereich:
$1.71
$1.8899
52-Wochen-Spanne:
$1.41
$2.37
Vivosim Labs Inc Stock (VIVS) Company Profile
Firmenname
Vivosim Labs Inc
Sektor
Branche
Telefon
858-224-1000
Adresse
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Vergleichen Sie VIVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.86 | 4.56M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Eingeleitet | Raymond James | Outperform |
| 2015-08-11 | Herabstufung | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Eingeleitet | Jefferies | Buy |
| 2015-06-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Vivosim Labs Inc Aktie (VIVS) Neueste Nachrichten
VivoSim Labs names Tony Lialin as chief commercial officer By Investing.com - Investing.com Australia
VivoSim Labs Appoints New Chief Commercial Officer - TipRanks
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - The Manila Times
AI-Powered Drug Testing Platform VivoSim Labs Taps Industry Veteran to Expand $641M Market Opportunity - Stock Titan
How to forecast VivoSim Labs Inc. trends using time series2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
Is VivoSim Labs Inc. stock ready for a breakoutJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Detecting price anomalies in VivoSim Labs Inc. with AIGap Up & High Yield Stock Recommendations - Newser
What risks could impact VivoSim Labs Inc. stock performanceJuly 2025 Setups & Technical Pattern Based Buy Signals - Newser
How to monitor VivoSim Labs Inc. with trend dashboardsRate Cut & Daily Profit Maximizing Trade Tips - Newser
What are some under 2 biotech ticker? Give their plans - AInvest
Elliott Wave Theory Predicts Pullback in VivoSim Labs Inc.Weekly Trade Analysis & Verified Swing Trading Watchlist - 선데이타임즈
Is it too late to sell VivoSim Labs Inc.2025 Price Targets & High Return Stock Watch Alerts - Newser
Will VivoSim Labs Inc. stock recover after recent dropJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
What makes VivoSim Labs Inc. stock price move sharplyMarket Growth Report & Technical Analysis for Trade Confirmation - Newser
Chart based analysis of VivoSim Labs Inc. trendsJuly 2025 Momentum & AI Enhanced Execution Alerts - Newser
VivoSim Labs 2026 Q1 Earnings Losses Narrowed by 15% - AInvest
Visual analytics tools that track VivoSim Labs Inc. performanceFree Weekly Growth Stock Entry Point Alerts - Newser
What institutions are buying VivoSim Labs Inc. stock nowMarket Performance Report & Fast Gain Swing Trade Alerts - Newser
Custom watchlist performance reports with VivoSim Labs Inc.Daily Pattern Analysis with Return Forecast - Newser
VivoSim: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
VivoSim Labs Inc. Enters Reversal Setup in Weekly ChartsLow Capital High Return Stock Plans Reviewed - 선데이타임즈
Understanding VivoSim Labs Inc.’s price movementFree Entry and Exit Strategy Optimizer Tool - Newser
Quantitative breakdown of VivoSim Labs Inc. recent moveEntry Timing with Downside Risk Analysis - Newser
Signal strength of VivoSim Labs Inc. stock in tech scannersLow-Risk Reversal Pattern Analysis Tracker - Newser
Intraday pattern recognizer results for VivoSim Labs Inc.Free Daily Top Performing Stock Insights - Newser
How VivoSim Labs Inc. stock performs during market volatilitySteady Return Plan Based on Data Analysis - Newser
Analyzing net buyer seller activity in VivoSim Labs Inc.Intraday Price Forecast Using Volume Models - Newser
Will VivoSim Labs Inc. stock go up soonAI Trade Signal Forecast with Chart Logic - Newser
Wyckoff Accumulation Phase Possible in VivoSim Labs Inc.Risk Adjusted Technical Entry Plan Gains Followers - beatles.ru
Key resistance and support levels for VivoSim Labs Inc.Free Step-by-Step Trade Signal Implementation - Newser
What moving averages say about VivoSim Labs Inc.Community Picked Stocks with Trade Insights - Newser
Finanzdaten der Vivosim Labs Inc-Aktie (VIVS)
Es liegen keine Finanzdaten für Vivosim Labs Inc (VIVS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):